Before chemotherapy is given, two trained staff check the drug, the dose and the patient. When treatment is given at home, the second person may now join by video. The 2024 US standards allow this but say no well-designed study has measured whether it is as safe.
The standard. The ASCO-ONS Antineoplastic Therapy Administration Safety Standards (2024) added a fourth verification at the patient's side and allow the second clinician to take part "through appropriate institutionally approved video-enabled technology, with at least one person on site".
The gap. The same document says that a review of remote verification found it "is feasible and may be alike live two-person checks; however, no well-designed research has evaluated the impact on safety", and cautions that reliance on technology can still lead to medication errors. Home administration is growing, so the number of checks done this way is likely to grow with it; how often it is used has not been measured.
Shares Infusion pumps, ports, and ambulatory chemotherapy devices and the tags protocol-upgrade, upgrade:untested.
Shares Infusion pumps, ports, and ambulatory chemotherapy devices and the tags protocol-upgrade, upgrade:untested.
Shares Fragmented care and guideline gaps and the tags protocol-upgrade, upgrade:untested.
Shares Fragmented care and guideline gaps and the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Shares the tags protocol-upgrade, upgrade:untested.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/